Ozempic, a diabetes drug, faces scrutiny over links to severe side effects like pancreatitis and thyroid cancer.

Ozempic, a popular diabetes and weight loss drug, has faced scrutiny due to potential severe side effects, including pancreatitis and thyroid cancer. Despite its effectiveness, patients and healthcare providers are urged to weigh the benefits against these risks carefully. The FDA is monitoring the situation and may update guidelines based on ongoing studies.